Pear Therapeutics Reports Second Quarter 2022 Results
20% quarter-over-quarter revenue growth to $3.3 million Recent real-world health economic data for all three of Pear’s commercial products show cost-savings1-3 Recent commercial formulary additions for reSET® and reSET-O® BOSTON--(BUSINESS WIRE)...